From: Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape
Patient characteristics
N = 100 (%)
Age
Median (Range)
57 (26–85)
Mean ± SE
55.3 ± 13.5
Gender
Male
52
Female
48
Stage
IIIB
11
IV
89
Smoking history
Ever-smokers
21
Never-smokers
64
Not assessed
15